Literatur
Moore K et al. N Engl J Med. 2018;379(26):2495–505
https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf
Ledermann JA et al. Ann Oncol. 2013;24 Suppl 6:vi24–32
Burger RA et al. N Engl J Med. 2011;365(26):2473–83
Perren TJ et al. N Engl J Med. 2011;365(26):2484–96
Literatur
Moore K et al. Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. N Engl J Med. 2018;379(26): 2495–505
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eichbaum, M., Eichbaum, C. Erhaltungstherapie mit Olaparib führt zu signifikant verlängertem PFS. Info Onkol. 22, 21–22 (2019). https://doi.org/10.1007/s15004-019-6424-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-019-6424-1